Gastrointestinal GI Stent Market Overview
The global Gastrointestinal GI Stent Market was valued at USD 2.21 billion in 2024 and is estimated to reach USD 2.30 billion in 2025. The market is projected to reach USD 3.5 billion by 2035, expanding at a CAGR of 4.2% during the forecast period from 2025 to 2035.
North America is expected to remain the leading regional market, valued at USD 900 million in 2024 and projected to reach USD 1.32 billion by 2035. Metal stents represented the largest product type segment, valued at USD 1.0 billion in 2024 and projected to reach USD 1.5 billion by 2035. Increasing prevalence of gastrointestinal disorders, rising adoption of minimally invasive procedures, technological advancements in stent design, an aging population, and favorable reimbursement policies are supporting market growth.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=615630
Key Companies in the Gastrointestinal GI Stent Market
Q Medical Devices
Boston Scientific
Terumo Corporation
Mauna Kea Technologies
ANGIODYNAMICS
Karl Storz
Endoquest
Hancu
Olympus Corporation
Medtronic
ITREAS
Johnson & Johnson
B. Braun Melsungen
Conmed Corporation
Cook Medical
The increasing prevalence of gastrointestinal disorders, including gastrointestinal cancers, biliary obstruction, esophageal strictures, and other blockages, is driving demand for GI stenting solutions. Technological advancements in self-expanding metallic stents, biodegradable materials, coatings, and delivery systems are improving treatment effectiveness and patient outcomes. Growing preference for minimally invasive and outpatient procedures is further supporting adoption, while expanding healthcare infrastructure and awareness in emerging markets are creating additional opportunities.
Market Segmentation
The Gastrointestinal GI Stent Market is segmented by Product Type into Plastic Stents, Metal Stents, Biodegradable Stents, and Vascular Stents. By Application, the market includes Biliary Obstruction, Gastro-Esophageal Obstruction, Colon Obstruction, and Pancreatic Obstruction. Based on Material, it is divided into Stainless Steel, Nitinol, Polymer, and Silicone. By End User, the market covers Hospitals, Ambulatory Surgical Centers, and Specialized Clinics. Regionally, the market includes North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
Recent Developments and Market Trends:
Boston Scientific announced the acquisition of EndoChoice to expand its gastrointestinal endoscopy portfolio and strengthen GI stent capabilities.
Terumo Corporation and Mauna Kea Technologies formed a strategic partnership to develop AI-assisted imaging solutions for GI stent placement.
Olympus Corporation launched a next-generation esophageal stent platform featuring improved conformability and radiopaque markers for enhanced deployment accuracy.
The development of biodegradable stents is gaining attention as manufacturers pursue patient-centric and environmentally conscious solutions.
Self-expanding metallic stents are increasingly preferred for complex gastrointestinal conditions because of their durability and clinical effectiveness.
Artificial intelligence and machine learning are emerging as potential tools for improving pre-operative planning, stent selection, placement, and patient monitoring.
Reasons to Buy the Report:
Understand the global Gastrointestinal GI Stent Market size, growth rate, and forecast through 2035.
Analyze opportunities across product types, applications, materials, end users, and major geographic regions.
Evaluate North America’s market leadership and the growth potential of Asia Pacific.
Identify leading companies and assess the competitive landscape of the GI stent industry.
Examine major market drivers, including gastrointestinal disease prevalence, minimally invasive procedures, and technological innovation.
Gain insights into emerging biodegradable materials, smart technologies, advanced delivery systems, and personalized treatment approaches.
Future Outlook:
The Gastrointestinal GI Stent Market is expected to maintain steady growth through 2035 as gastrointestinal disorders become more prevalent and healthcare providers increasingly adopt minimally invasive treatment approaches. Continued innovation in metallic, biodegradable, polymer, and smart stent technologies is expected to improve procedural efficiency and patient outcomes. North America is likely to retain its leading position, while Asia Pacific is expected to offer significant growth opportunities as healthcare infrastructure, awareness, and access to advanced gastrointestinal procedures continue to expand.
➤➤Explore Our Latest Related Reports:
